Unknown

Dataset Information

0

Prevalence of amyloid-? pathology in distinct variants of primary progressive aphasia.


ABSTRACT: OBJECTIVE:To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in primary progressive aphasia (PPA) variants. METHODS:We conducted a meta-analysis with individual participant data from 1,251 patients diagnosed with PPA (including logopenic [lvPPA, n?=?443], nonfluent [nfvPPA, n?=?333], semantic [svPPA, n?=?401], and mixed/unclassifiable [n?=?74] variants of PPA) from 36 centers, with a measure of amyloid-? pathology (CSF [n?=?600], PET [n?=?366], and/or autopsy [n?=?378]) available. The estimated prevalence of amyloid positivity according to PPA variant, age, and apolipoprotein E (ApoE) ?4 status was determined using generalized estimating equation models. RESULTS:Amyloid-? positivity was more prevalent in lvPPA (86%) than in nfvPPA (20%) or svPPA (16%; p?

SUBMITTER: Bergeron D 

PROVIDER: S-EPMC6354051 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Bergeron David D   Gorno-Tempini Maria L ML   Rabinovici Gil D GD   Santos-Santos Miguel A MA   Seeley William W   Miller Bruce L BL   Pijnenburg Yolande Y   Keulen M Antoinette MA   Groot Colin C   van Berckel Bart N M BNM   van der Flier Wiesje M WM   Scheltens Philip P   Rohrer Jonathan D JD   Warren Jason D JD   Schott Jonathan M JM   Fox Nick C NC   Sanchez-Valle Raquel R   Grau-Rivera Oriol O   Gelpi Ellen E   Seelaar Harro H   Papma Janne M JM   van Swieten John C JC   Hodges John R JR   Leyton Cristian E CE   Piguet Olivier O   Rogalski Emily J EJ   Mesulam Marsel M MM   Koric Lejla L   Kristensen Nora N   Pariente Jeéreémie J   Dickerson Bradford B   Mackenzie Ian R IR   Hsiung Ging-Yuek R GR   Belliard Serge S   Irwin David J DJ   Wolk David A DA   Grossman Murray M   Jones Matthew M   Harris Jennifer J   Mann David D   Snowden Julie S JS   Chrem-Mendez Patricio P   Calandri Ismael L IL   Amengual Alejandra A AA   Miguet-Alfonsi Carole C   Magnin Eloi E   Magnani Giuseppe G   Santangelo Roberto R   Deramecourt Vincent V   Pasquier Florence F   Mattsson Niklas N   Nilsson Christer C   Hansson Oskar O   Keith Julia J   Masellis Mario M   Black Sandra E SE   Matías-Guiu Jordi A JA   Cabrera-Martin María-Nieves MN   Paquet Claire C   Dumurgier Julien J   Teichmann Marc M   Sarazin Marie M   Bottlaender Michel M   Dubois Bruno B   Rowe Christopher C CC   Villemagne Victor L VL   Vandenberghe Rik R   Granadillo Elias E   Teng Edmond E   Mendez Mario M   Meyer Philipp T PT   Frings Lars L   Lleó Alberto A   Blesa Rafael R   Fortea Juan J   Seo Sang Won SW   Diehl-Schmid Janine J   Grimmer Timo T   Frederiksen Kristian Steen KS   Sánchez-Juan Pascual P   Chételat Gaël G   Jansen Willemijn W   Bouchard Rémi W RW   Laforce Robert Jr RJ   Visser Pieter Jelle PJ   Ossenkoppele Rik R  

Annals of neurology 20181101 5


<h4>Objective</h4>To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in primary progressive aphasia (PPA) variants.<h4>Methods</h4>We conducted a meta-analysis with individual participant data from 1,251 patients diagnosed with PPA (including logopenic [lvPPA, n = 443], nonfluent [nfvPPA, n = 333], semantic [svPPA, n = 401], and mixed/unclassifiable [n = 74] variants of PPA) fr  ...[more]

Similar Datasets

| S-EPMC5421819 | biostudies-literature
| S-EPMC2648510 | biostudies-literature
| S-EPMC5841154 | biostudies-literature
| S-EPMC6208807 | biostudies-literature
| S-EPMC10472914 | biostudies-literature
| S-EPMC4789129 | biostudies-literature
| S-EPMC5567322 | biostudies-literature
| S-EPMC4380294 | biostudies-literature
| S-EPMC5885868 | biostudies-literature
| S-EPMC4762414 | biostudies-literature